Cell Therapeutics

I have been following Cell Therapeutics (CTIC) since the beginning of 2009. When I first posted them as a buy they were in the 30 cent range and they had gone as high as $1.85. When they got to the $1.40 range I expressed my concern about holding them as a recommendation to sell and they shortly went into the 90 cent range. Now they are holding around $1 but I would watch out for them in the next couple of months as Pixantrone is up for approval decision in April and this could bring in a nice profit. I cannot guarantee a profit with any stock and I cannot guarantee that Pixantrone will be approved however I do not see any reason that it will not be approved. I believe that Cell Therapeutics (CTIC) has hit their low.